JUPITER, Florida – September 9, 2024 — Ascendiant Capital Markets LLC (“Ascendiant”) announced today the filing of an amendment to its At-the-Market (ATM) Offering for Allarity Therapeutics, Inc. (Nasdaq: ALLR) of Boston, Massachusetts, increasing the amount to $50,000,000.
Ascendiant is serving as Sole Sales Agent on the financing transaction. To view this announcement, click here.